Novo Nordisk Statistics

Total Valuation

Novo Nordisk has a market cap or net worth of DKK 3.21 trillion. The enterprise value is 3.19 trillion.

Market Cap	3.21T
Enterprise Value	3.19T

Important Dates

The last earnings date was Wednesday, November 6, 2024.

Earnings Date	Nov 6, 2024
Ex-Dividend Date	Aug 15, 2024

Share Statistics

Novo Nordisk has 4.44 billion shares outstanding. The number of shares has decreased by -0.86% in one year.

Current Share Class	n/a
Shares Outstanding	4.44B
Shares Change (YoY)	-0.86%
Shares Change (QoQ)	-0.11%
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	33.57%
Float	3.17B

Valuation Ratios

The trailing PE ratio is 34.05 and the forward PE ratio is 27.28. Novo Nordisk's PEG ratio is 1.34.

PE Ratio	34.05
Forward PE	27.28
PS Ratio	11.89
PB Ratio	26.66
P/TBV Ratio	n/a
P/FCF Ratio	41.25
P/OCF Ratio	n/a
PEG Ratio	1.34

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 24.77, with an EV/FCF ratio of 41.02.

EV / Earnings	33.67
EV / Sales	11.79
EV / EBITDA	24.77
EV / EBIT	26.61
EV / FCF	41.02

Financial Position

The company has a current ratio of 0.94, with a Debt / Equity ratio of 0.47.

Current Ratio	0.94
Quick Ratio	0.74
Debt / Equity	0.47
Debt / EBITDA	0.44
Debt / FCF	0.73
Interest Coverage	788.08

Financial Efficiency

Return on equity (ROE) is 88.73% and return on invested capital (ROIC) is 50.41%.

Return on Equity (ROE)	88.73%
Return on Assets (ROA)	21.47%
Return on Capital (ROIC)	50.41%
Revenue Per Employee	3.76M
Profits Per Employee	1.32M
Employee Count	64,319
Asset Turnover	0.78
Inventory Turnover	1.23

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.66% in the last 52 weeks. The beta is 0.15, so Novo Nordisk's price volatility has been lower than the market average.

Beta (5Y)	0.15
52-Week Price Change	+2.66%
50-Day Moving Average	793.92
200-Day Moving Average	877.99
Relative Strength Index (RSI)	39.09
Average Volume (20 Days)	3,703,984

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novo Nordisk had revenue of DKK 270.58 billion and earned 94.72 billion in profits. Earnings per share was 21.20.

Revenue	270.58B
Gross Profit	229.07B
Operating Income	119.79B
Pretax Income	119.25B
Net Income	94.72B
EBITDA	127.40B
EBIT	119.79B
Earnings Per Share (EPS)	21.20

Full Income Statement

Balance Sheet

The company has 74.88 billion in cash and 56.97 billion in debt, giving a net cash position of 17.91 billion or 4.03 per share.

Cash & Cash Equivalents	74.88B
Total Debt	56.97B
Net Cash	17.91B
Net Cash Per Share	4.03
Equity (Book Value)	120.52B
Book Value Per Share	27.07
Working Capital	-13.20B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 118.22 billion and capital expenditures -40.47 billion, giving a free cash flow of 77.75 billion.

Operating Cash Flow	118.22B
Capital Expenditures	-40.47B
Free Cash Flow	77.75B
FCF Per Share	17.50

Full Cash Flow Statement

Margins

Gross margin is 84.66%, with operating and profit margins of 44.27% and 35.01%.

Gross Margin	84.66%
Operating Margin	44.27%
Pretax Margin	44.07%
Profit Margin	35.01%
EBITDA Margin	47.08%
EBIT Margin	44.27%
FCF Margin	28.73%

Dividends & Yields

This stock pays an annual dividend of 9.90, which amounts to a dividend yield of 1.34%.

Dividend Per Share	9.90
Dividend Yield	1.34%
Dividend Growth (YoY)	39.93%
Years of Dividend Growth	6
Payout Ratio	46.60%
Buyback Yield	0.86%
Shareholder Yield	2.20%
Earnings Yield	2.94%
FCF Yield	2.42%

Dividend Details

Stock Splits

The last stock split was on September 13, 2023. It was a forward split with a ratio of 2.

Last Split Date	Sep 13, 2023
Split Type	Forward
Split Ratio	2

Scores

Novo Nordisk has an Altman Z-Score of 10.08.

Altman Z-Score	10.08
Piotroski F-Score	n/a